Literature DB >> 24222636

Quantitative control of intracellular signaling activity through chimeric receptors incorporating multiple identical tyrosine motifs.

Koichiro Saka1, Masahiro Kawahara, Teruyuki Nagamune.   

Abstract

Controlling activation levels and durations of native signaling molecules is important for efficiently controlling cellular fates. Previously we developed single-chain Fv (scFv)/cytokine receptor chimeras incorporating tyrosine motifs in the intracellular domain, which artificially control the activation of specific intracellular signaling proteins. In this study, to quantitatively control the activation levels of signaling molecules with an extended dynamic range, we constructed scFv/receptor chimeras incorporating multiple identical motifs at the different positions in the intracellular domain. We used retroviral transduction to express chimeric receptors with multiple STAT3 binding motifs connected with or without flexible linkers in a murine IL-3-dependent pro-B cell line, Ba/F3. Our results showed that the chimeric receptors can control the activation levels of STAT3 depending on ligand concentration and the number of motifs. The existence of linkers between the motifs also affected the signal intensity. Furthermore, the STAT3 activation levels significantly depended on the number of motifs rather than the distance from the JAK-binding region to the tyrosine motif.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  antibody; chimeric protein; receptor; signal transduction; tyrosine motif

Mesh:

Substances:

Year:  2013        PMID: 24222636     DOI: 10.1002/bit.25151

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  2 in total

Review 1.  Biomolecular engineering for nanobio/bionanotechnology.

Authors:  Teruyuki Nagamune
Journal:  Nano Converg       Date:  2017-04-24

2.  Boolean immunotherapy: reversal of fortune.

Authors:  Richard A Morgan
Journal:  Mol Ther       Date:  2014-06       Impact factor: 11.454

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.